Kasai H, Tonda K, Hirata M
Cancer Chemother Pharmacol. 1986;16(1):55-7. doi: 10.1007/BF00255286.
The effect of acetazolamide (A.A.) on the antineoplastic activity of 1-phthalidyl 5-fluorouracil (PH-FU) against rat and mouse solid tumors was examined. A.A., an inhibitor of liver PH-FU hydrolase, had no antitumor activity but greatly enhanced the activity of PH-FU when coadministered. The potentiation was evaluated in terms of suppression of tumor growth and prolongation of the life-span of tumor-bearing animals. Studies also revealed that A.A. elevated the concentration of PH-FU in tumor tissues, where 5-fluorouracil is slowly liberated from PH-FU. The results are consistent with the hypothesis that A.A. prevents enzymic degradation of PH-FU in the liver and promotes its distribution into target organs.
研究了乙酰唑胺(A.A.)对1-邻苯二甲酰基-5-氟尿嘧啶(PH-FU)抗大鼠和小鼠实体瘤抗肿瘤活性的影响。A.A.是肝脏PH-FU水解酶的抑制剂,本身无抗肿瘤活性,但与PH-FU联合给药时能显著增强其活性。通过抑制肿瘤生长和延长荷瘤动物寿命来评估这种增效作用。研究还表明,A.A.提高了肿瘤组织中PH-FU的浓度,在肿瘤组织中5-氟尿嘧啶从PH-FU中缓慢释放。这些结果与以下假设一致:A.A.可防止肝脏中PH-FU的酶促降解,并促进其向靶器官分布。